Clinical outcomes of interlocking main pancreatic duct-jejunal internal bridge drainage in middle pancreatectomy: A comparative study

Table 3 Postoperative outcomes of patients who underwent interlocking main pancreatic duct-jejunal bridge drainage or duct-to-mucosa pancreaticojejunostomy

	IMPD-J bridge drainage (n = 23)	Duct-to-mucosa pancreaticojejunostomy (n = 30)	χ²/t/z	P value
Temperature > 38.5 °C, n (%)	5 (21.7)	5 (16.7)	0.013	0.910
Blood culture (positive), n (%)	0 (0)	2 (6.7)	NA	0.499
Drainage tube infection, n (%)	4 (17.4)	4 (13.3)	NA	0.715
Nasogastric tube retention, days	5.3 ± 1.7	6.5 ± 2.0	-2.218	0.031
DGE, n (%)	2 (8.7)	11 (36.7)	5.502	0.019
Peritoneal effusion, n (%)	1 (4.4)	6 (20.0)	2.782	0.095
Intervention/endoscopic treatment, n (%)	0 (0)	1 (3.3)	NA	1.000
Postoperative bleeding, n (%)	1 (4.4)	1 (3.3)	NA	1.000
Length of hospital stay, days	24.0 (14.0, 29.0)	29 (9.8, 40.3)	-0.844	0.399
Drainage tube retention time, days	20.0 (13.0, 36.0)	27 (17.8, 40.0)	-1.096	0.273
POPF 0, n (%)	6 (26.1)	5 (16.7)	NA	NA
A, n (%)	8 (34.8)	4 (13.3)	NA	NA
B, n (%)	8 (34.8)	21 (70.0)	NA	NA
C, n (%)	1 (4.4)	0 (0)	NA	NA
CR-POPF, n (%)	9 (39.1)	21 (70.0)	5.051	0.025

IMPD-J: Interlocking main pancreatic duct-jejunal; NA: Not available; DGE: Delayed gastric emptying; POPF: Postoperative pancreatic fistula; CR-POPF: Clinically relevant postoperative pancreatic fistula.